Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism RNA splicing modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Skyhawk Therapeutics, Inc.Startup |
Active Organization Skyhawk Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Discovery | US | Skyhawk Therapeutics, Inc.Startup | 01 Oct 2024 |